Theradiag S.A.
$1.26▼ 4.91%($-0.07)
TickerSpark Score
57/100
▌ Mixed
70
Valuation
35
Profitability
80
Growth
68
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALTER.PA research report →
52-Week Range7% of range
Low
$1.18
Current
$1.26
High
$2.39
Company Overviewwww.theradiag.com
About the company
Theradiag S. A. specializes in the creation, production, and marketing of in-vitro diagnostic solutions.
- CEO
- Simon Daviere
- IPO
- 2012
- Employees
- 60
- HQ
- Marne-la-Vallée, FR
Price Chart
-44.98% · this period
Valuation
- Market Cap
- $17.29M
- P/E
- -33.60
- P/S
- 1.42
- P/B
- 1.94
- EV/EBITDA
- 51.94
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 44.81%
- Op Margin
- -2.25%
- Net Margin
- -4.00%
- ROE
- -5.61%
- ROIC
- -1.62%
Growth & Income
- Revenue
- $12.20M · 9.71%
- Net Income
- $-487,582 · 36.43%
- EPS
- $-0.04 · 36.33%
- Op Income
- $-274,138
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $2.39
- 52W Low
- $1.18
- 50D MA
- $1.43
- 200D MA
- $1.99
- Beta
- -0.27
- Avg Volume
- 4.07K
Get TickerSpark's AI analysis on ALTER.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · ALTER.PA
Our ALTER.PA coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on ALTER.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALTER.PA report →Internal Compare
Similar companies
Peers in the same neighborhood.